Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Research & Development history
Currency unavailable · from the income statement
No Research & Development data reported for this period type.
Research & Development vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $394.1M USD | +0.9% | +19.0% | 555.4% | |
| LTM Jun 2026 | $148.75M USD | +4.1% | +17.8% | 2088.9% | |
| LTM Mar 2026 | $62.37M USD | -24.6% | -10.1% | 27721.8% | |
| FY2025 | $53.76M USD | — | — | 288.7% | |
| LTM Mar 2026 | $30.12M USD | +20.6% | +35.3% | — | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +2.5% | +18.4% | 1322.1% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.